
Advancing cardiovascular drug discovery with iPSC-Derived 3D cardiac microtissues in High-Throughput Screening

Development of a robust and scalable iPSC platform for predictions of efficacy and in vivo toxicity of RNA therapeutics early in the drug discovery pipeline

Building manufacturing processes for reproducible, multi-yeariPSC-based drug screening

Human iPSC Tri-Culture for Alzheimer’s Disease Poster

iPSC-Based Parkinson’s Disease Model Poster

iPSC Platforms for RNA Therapeutics Efficacy & In Vivo Toxicity Poster
